Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury
Author:
Affiliation:
1. Department of Pharmaceutical Engineering; Tianjin University; Tianjin China
2. Beijing Institute of Radiation Medicine; Beijing China
3. State Key Laboratory of Proteomics; Beijing China
Funder
Special Funds for Major State Basic Research of China
National High-Tech Research and Development Program
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29140/fullpdf
Reference35 articles.
1. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors;Kawai;Nat Immunol,2010
2. Toll-like receptors as targets in chronic liver diseases;Mencin;Gut,2009
3. Blocking TLR2 in vivo attenuates experimental hepatitis induced by concanavalin A in mice;Zhou;Int Immunopharmacol,2014
4. Inflammatory regulation by TLR3 in acute hepatitis;Xiao;J Immunol,2009
5. Gut-derived lipopolysaccharide promotes T-cell-mediated hepatitis in mice through Toll-like receptor 4;Lin;Cancer Prev Res (Phila),2012
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Toll-like Receptor Agonist CBLB502 Protects Against Radiation-induced Intestinal Injury in Mice;In Vivo;2024
2. Toll-like Receptor Agonist CBLB502 Protects Against Cisplatin-induced Liver and Kidney Damage in Mice;In Vivo;2023
3. The immunological mechanisms and therapeutic potential in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity;Cell & Bioscience;2022-11-22
4. Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes;Frontiers in Pharmacology;2022-09-15
5. Targeted and activatable nanosystem for fluorescent and optoacoustic imaging of immune-mediated inflammatory diseases and therapy via inhibiting NF-κB/NLRP3 pathways;Bioactive Materials;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3